As a cardiac surgeon, you deal with a lot of challenges: judging the risks of a procedure, determining patients’ tolerance for contrast media, and anticipating reinterventions and follow-up procedures.
Our imaging systems with procedural intelligence allow you to address these challenges. You can optimize clinical outcomes for every patient thanks to continuous image guidance, optimized image quality at the lowest possible dose, and standardized workflow steps. Whether you are positioning valves, performing bypass surgery, or placing stent grafts, our systems are the ideal enabler for minimally invasive treatment in the Hybrid OR.
Cardiac procedures with Hybrid OR imaging solutions
Hybrid OR imaging solutions help optimize clinical operations in the Hybrid OR, enabling precision valve placement with standardized workflow steps.
TAVI procedures in the Hybrid OR with fusion imaging
Our imaging systems help standardize your TAVI procedures by simplifying image acquisition, automating planning, guiding valve deployment, and enabling immediate verification.
Hybrid Coronary Revascularization
Our Hybrid OR solutions are suitable for hybrid coronary revascularization procedures, allowing you to improve treatment of multivessel coronary heart disease. Hybrid coronary revascularization is a minimally invasive approach that combines the durability and survival advantage of the LIMA-LAD graft with PCI for the non-LAD vessels, potentially reducing the cumulative MACCE rate2,3. With real-time image stabilization during stent deployment and material-sensitive imaging at the lowest reasonable dose, our systems empower you to provide optimal treatment for every patient.
Our Hybrid OR imaging solutions
Success story: University Hospital of Giessen and Marburg
The University Hospital of Giessen and Marburg (UKGM) was the first to use ARTIS pheno for cardiology and cardio-vascular surgery. As a full-service provider, the UKGM serves a local population of about 300,000. Prof. Bernhard Schieffer, MD, is the director of the Clinic of Cardiology, Angiology and Intensive Care at the University Hospital in Marburg. We asked him about his initial experience with ARTIS pheno after the first month of operation.
Interview with Prof. Bernhard Schieffer, MD, Director of Cardiology, University Hospital Marburg, Germany, May 10, 2017.
Scientific Talks and Publications
The statements with footnotes in this document are based on a result of the quoted clinical study that evaluates the procedure. The results are not generated with the actual product version. It is expected, that the actual product version has similar or improved functionality to support the evaluated procedure.
Some/All of the features and products described herein may not be available in the United States or other countries.
1Karl K. Poon et al., “Impact of Optimising Fluoroscopic Implant Angles on Paravalvular Regurgitation in Transcatheter Aortic Valve Replacements – Utility of Three-Dimensional Rotational Angiography,” EuroIntervention 8, no. 5(2012): 538–45, http://doi.org/10.4244/EIJV8I5A84.
2Liuzhong Shen et al., “One-Stop Hybrid Coronary Revascularization Versus Coronary Artery Bypass Grafting and Percutaneous Coronary Intervention for the Treatment of Multivessel Coronary Artery Disease: 3-Year Follow-Up Results from a Single Institution,” Journal of the American College of Cardiology 61, no. 25 (2013): 2525–2533, http://doi.org/10.1016/j.jacc.2013.04.007.
3David X. Zhao et al., “Routine Intraoperative Completion Angiography After Coronary Artery Bypass Grafting and 1-Stop Hybrid Revascularization,” Journal of the American College of Cardiology 53, no. 3 (2009): 232–241, http://doi.org/10.1016/j.jacc.2008.10.011.